Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 82

1.

Letter Response.

Tan S, Buzney E, Mostaghimi A.

J Am Acad Dermatol. 2018 Dec 21. pii: S0190-9622(18)33097-4. doi: 10.1016/j.jaad.2018.12.025. [Epub ahead of print] No abstract available.

PMID:
30582990
2.

Two cases of maggot debridement therapy in pyoderma gangrenosum.

Din RS, Tsiaras WG, Mostaghimi A.

JAAD Case Rep. 2018 Nov 10;4(10):1027-1029. doi: 10.1016/j.jdcr.2018.07.016. eCollection 2018 Nov. No abstract available.

3.

Association Between Market Competition and Prices of Generic Topical Dermatology Drugs.

Li DG, Joyce C, Mostaghimi A.

JAMA Dermatol. 2018 Dec 1;154(12):1441-1446. doi: 10.1001/jamadermatol.2018.3798.

PMID:
30383117
4.

Efficacy of Systemic Dapsone Treatment for Pyoderma Gangrenosum: A Retrospective Review.

Din RS, Tsiaras WG, Li DG, Mostaghimi A.

J Drugs Dermatol. 2018 Oct 1;17(10):1058-1060.

PMID:
30365585
5.

Translating Administrative Health Care Data to Treatment Decisions in Dermatology: The Blind Men and the Elephant.

Mostaghimi A, Adamson AS.

JAMA Dermatol. 2018 Nov 1;154(11):1256-1257. doi: 10.1001/jamadermatol.2018.3063. No abstract available.

PMID:
30326491
6.

Impact of Industry Payments on Prescribing Patterns for Tumor Necrosis Factor Inhibitors Among Medicare Beneficiaries.

Singh P, Forman H, Adamson AS, Mostaghimi A, Ogdie AR, Oganisian A, Barbieri JS.

J Gen Intern Med. 2018 Oct 15. doi: 10.1007/s11606-018-4698-x. [Epub ahead of print] No abstract available.

PMID:
30324292
7.

Evaluating the Efficacy of Topical Dapsone Treatment for Pyoderma Gangrenosum: A Retrospective Case Series.

Li DG, Din RS, Tsiaras WG, Mostaghimi A.

J Cutan Med Surg. 2018 Nov/Dec;22(6):650-651. doi: 10.1177/1203475418782140. No abstract available.

PMID:
30322308
8.

Two Cases of Severe Erosive Pustular Dermatosis Mimicking Infection.

Din RS, Tsiaras WG, Mostaghimi A.

Wounds. 2018 Aug;30(8):E84-E86.

9.

Clinical Diagnostic Accuracy of Onychomycosis: A Multispecialty Comparison Study.

Li DG, Cohen JM, Mikailov A, Williams RF, Laga AC, Mostaghimi A.

Dermatol Res Pract. 2018 Jul 3;2018:2630176. doi: 10.1155/2018/2630176. eCollection 2018.

10.

Factors Influencing Patient Decisions Regarding Treatments for Skin Growths: A Cross-Sectional Study.

Li DG, Xia FD, Rana J, Young GJ, Alizadeh F, Joyce C, Das S, Mostaghimi A.

Dermatol Res Pract. 2018 Jun 19;2018:3941347. doi: 10.1155/2018/3941347. eCollection 2018.

11.

Cost of Routine Herpes Simplex Virus Infection Visits to U.S. Emergency Departments 2006-2013.

Di Xia F, Fuhlbrigge M, Dommasch E, Joyce C, Mostaghimi A.

West J Emerg Med. 2018 Jul;19(4):689-692. doi: 10.5811/westjem.2018.3.37543. Epub 2018 Jun 4.

12.

Reply to: "Re-evaluating pyoderma gangrenosum patients for Beh├žet disease before initiating any invasive procedures is essential".

Mostaghimi A, Joyce C.

J Am Acad Dermatol. 2018 Aug;79(2):e33. doi: 10.1016/j.jaad.2018.03.050. No abstract available.

PMID:
30012288
13.

The ALT-70 predictive model outperforms thermal imaging for the diagnosis of lower extremity cellulitis: A prospective evaluation.

Li DG, Dewan AK, Xia FD, Khosravi H, Joyce C, Mostaghimi A.

J Am Acad Dermatol. 2018 Dec;79(6):1076-1080.e1. doi: 10.1016/j.jaad.2018.06.062. Epub 2018 Jul 10.

PMID:
30003987
14.

Cost-effectiveness of Confirmatory Testing and Empirical Therapy for Onychomycosis in Canada.

Li DG, Din RS, Mostaghimi A.

J Cutan Med Surg. 2018 Mar/Apr;22(2):242-243. doi: 10.1177/1203475417746124. No abstract available.

PMID:
29995445
15.

Patient factors associated with nationwide emergency department utilization for cellulitis.

Li DG, Joyce C, Mostaghimi A.

Am J Emerg Med. 2018 Jun 18. pii: S0735-6757(18)30502-3. doi: 10.1016/j.ajem.2018.06.037. [Epub ahead of print] No abstract available.

PMID:
29958742
16.

Mass Compression from Recurrent Lymphoma Mimicking Lower Extremity Cellulitis.

Li DG, Krajewski KM, Mostaghimi A.

Cureus. 2018 Apr 12;10(4):e2466. doi: 10.7759/cureus.2466.

17.

Development and pilot-testing of the Alopecia Areata Assessment Tool (ALTO).

Li DG, Huang KP, Xia FD, Joyce C, Scott DA, Qureshi AA, Mostaghimi A.

PLoS One. 2018 Jun 6;13(6):e0196517. doi: 10.1371/journal.pone.0196517. eCollection 2018.

18.

Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United States.

Micheletti RG, Chiesa-Fuxench Z, Noe MH, Stephen S, Aleshin M, Agarwal A, Boggs J, Cardones AR, Chen JK, Cotliar J, Davis MDP, Dominguez A, Fox LP, Gordon S, Hamrick R, Ho B, Hughey LC, Jones LM, Kaffenberger BH, Kindley K, Kroshinsky D, Kwong BY, Miller DD, Mostaghimi A, Musiek A, Ortega-Loayza AG, Patel R, Posligua A, Rani M, Saluja S, Sharon VR, Shinkai K, John JS, Strickland N, Summers EM, Sun N, Wanat KA, Wetter DA, Worswick S, Yang C, Margolis DJ, Gelfand JM, Rosenbach M.

J Invest Dermatol. 2018 Nov;138(11):2315-2321. doi: 10.1016/j.jid.2018.04.027. Epub 2018 Jul 27.

PMID:
29758282
19.

The Challenges of Big Data in Dermatology.

Noe MH, Mostaghimi A.

J Am Acad Dermatol. 2018 May 9. pii: S0190-9622(18)30664-9. doi: 10.1016/j.jaad.2018.03.059. [Epub ahead of print] No abstract available.

PMID:
29753065
20.

Trends in phototherapy utilization among Medicare beneficiaries in the United States, 2000 to 2015.

Tan SY, Buzney E, Mostaghimi A.

J Am Acad Dermatol. 2018 Oct;79(4):672-679. doi: 10.1016/j.jaad.2018.03.018. Epub 2018 Mar 21.

PMID:
29574089

Supplemental Content

Loading ...
Support Center